Polish Pharmaceuticals & Biotech Most Popular Stocks

Celon Pharma

Market Cap: zł1.1b

An integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products.

Selvita

Market Cap: zł558.9m

Provides drug discovery, drug development, and contract testing services in Poland.

Syn2bio

Market Cap: zł557.0m

A biotechnology company, engages in the research and commercialization of Cardiac Marker, a radiopharmaceutical for diagnostic testing of heart disease in the field of myocardial perfusion.

Bioceltix

Market Cap: zł491.3m

Engages in the development of stem cell-based biopharmaceuticals for veterinary use.

Captor Therapeutics Spolka Akcyjna

Market Cap: zł479.7m

A biopharmaceutical company, develops therapeutic molecules for treating oncological and autoimmune diseases in Poland.

Ryvu Therapeutics

Market Cap: zł343.1m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

BIOTON

Market Cap: zł330.1m

A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.

Synthaverse

Market Cap: zł212.9m

A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.

Molecure

Market Cap: zł116.8m

A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.

Mabion

Market Cap: zł116.7m

A biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.

Poltreg

Market Cap: zł111.2m

A biotechnology company, researches and develops therapies for autoimmune diseases.

NanoGroup

Market Cap: zł104.0m

Operates as a biotechnology company in Poland.

HyEnergy

Market Cap: zł77.9m

Provides genetic diagnostic solutions in Poland.

Urteste

Market Cap: zł73.3m

Engages in the research and development of diagnostic tests for cancers.

Genomtec

Market Cap: zł71.0m

Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.

Read-Gene

Market Cap: zł54.2m

Engages in the detection, prevention, and treatment of various types of cancer.

Biogened

Market Cap: zł45.0m

Produces and sells cosmetics and toiletries in Poland.

Genomed Spólka Akcyjna

Market Cap: zł39.1m

Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

Medicofarma Biotech

Market Cap: zł27.9m

Engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.

Pure Biologics

Market Cap: zł26.6m

A biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.

genXone

Market Cap: zł20.1m

Operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally.

Stem Cells Spin

Market Cap: zł16.5m

Operates as a biotechnology company in Poland.

Green Zebras Spolka Akcyjna

Market Cap: zł14.0m

Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.

Cannabis Poland

Market Cap: zł13.5m

Operates in the medical cannabis industry in Poland.

Tecnovatica

Market Cap: zł5.5m

Engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.

Labocanna

Market Cap: zł4.7m

Engages in the cultivation, production, and distribution of hemp product.